 |
| |
| Aug-09-17 | Upgrade |
Ladenburg Thalmann |
Neutral → Buy |
|
|
| Sep-20-16 | Reiterated |
Chardan Capital Markets |
Neutral |
$5.75 → $1.50 |
|
| Sep-16-16 | Reiterated |
FBR & Co. |
Outperform |
$17 → $12 |
|
| Sep-16-16 | Downgrade |
Wedbush |
Outperform → Neutral |
$14 → $2 |
|
| Sep-16-16 | Downgrade |
Piper Jaffray |
Overweight → Neutral |
|
|
| Sep-16-16 | Downgrade |
Ladenburg Thalmann |
Buy → Neutral |
|
|
| Sep-16-16 | Downgrade |
JP Morgan |
Overweight → Neutral |
|
|
| Sep-16-16 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
| Apr-04-16 | Initiated |
Chardan Capital Markets |
Neutral |
$5.75 |
|
| Jul-09-15 | Reiterated |
Citigroup |
Buy |
$10 → $18 |
|
| Jun-09-15 | Initiated |
Guggenheim |
Buy |
|
|
| Mar-11-14 | Reiterated |
Ladenburg Thalmann |
Buy |
$4 → $10 |
|
| Oct-30-13 | Initiated |
FBR Capital |
Outperform |
$11 |
|
| Sep-25-13 | Reiterated |
MLV & Co |
Buy |
$8.50 → $9.50 |
|
| Mar-15-11 | Initiated |
Wedbush |
Outperform |
$6 |
|
| Jun-15-10 | Initiated |
Dawson James |
Buy |
$4.50 |
|
| Mar-15-10 | Initiated |
Roth Capital |
Buy |
$5 |
|
| Dec-03-09 | Initiated |
Global Hunter Securities |
Buy |
$7.25 |
|
| Dec-01-09 | Initiated |
Piper Jaffray |
Overweight |
$4.50 |
|
| Nov-05-09 | Initiated |
Merriman |
Buy |
$7 |
|
|
|
| Sep-19-17 04:05PM | Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference GlobeNewswire |
| 09:06AM | Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults GlobeNewswire |
| 09:05AM | Novavax Initiates Phase 1/2 Trial of NanoFlu Vaccine in Older Adults GlobeNewswire |
| Sep-05-17 09:38PM | ETFs with exposure to Novavax, Inc. : September 6, 2017 Capital Cube |
| 04:05PM | Novavax to Participate in the Citi 12th Annual Biotech Conference GlobeNewswire |
| 08:00AM | Today's Research Reports on Trending Tickers: DryShips Inc. and Seadrill Ltd. ACCESSWIRE |
| Sep-01-17 08:25AM | 3 Stocks That Could Soar More Than Amazon Motley Fool |
| Aug-25-17 05:04PM | ETFs with exposure to Novavax, Inc. : August 25, 2017 Capital Cube |
| 12:08PM | Better Buy: Inovio Pharmaceuticals, Inc. vs. Novavax, Inc. Motley Fool |
| Aug-23-17 07:01AM | Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine GlobeNewswire |
| Aug-19-17 12:03PM | 3 Top Biotech Stocks Under $10 Motley Fool |
| Aug-16-17 09:58AM | Novavax, Inc. :NVAX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube |
| Aug-15-17 03:02PM | The Hidden Gem in Novavax's Pipeline You'll Want to Watch Motley Fool |
| Aug-13-17 09:47PM | Edited Transcript of NVAX earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents |
| Aug-12-17 02:51PM | Where Does Zika Virus Vaccine Research Stand Now? Benzinga |
| Aug-10-17 09:37AM | Can Novavax Stage A Comeback In Q4? One Analyst Thinks So Benzinga |
| Aug-09-17 11:32PM | Novavax reports 2Q loss Associated Press |
| Aug-08-17 04:06PM | Novavax Reports Second Quarter 2017 Financial Results GlobeNewswire |
| 10:10AM | Investor Network: Novavax, Inc to Host Earnings Call ACCESSWIRE |
| Aug-07-17 06:26PM | Novavax, Inc. Value Analysis (NASDAQ:NVAX) : August 7, 2017 Capital Cube |
| Aug-01-17 04:06PM | Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017 GlobeNewswire |
| 03:02PM | The Single Best Reason to Buy Novavax Stock Now Motley Fool |
| Jul-28-17 03:08PM | We Spoke With The Experts, And Learned The Secrets Behind Beating The Penny Stock Market Benzinga -5.92% |
| Jul-27-17 10:31AM | Novavax, Inc.: Buy the Dip? Motley Fool -6.42% |
| Jul-26-17 09:34AM | Novavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : July 26, 2017 Capital Cube |
| Jul-25-17 12:35PM | Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite TheStreet.com -27.15% |
| 12:27PM | Why Novavax, Inc Is Tanking Today Motley Fool |
| 09:09AM | Novavax, Inc. (NVAX) Shares Tumble on Clinical Data; Cantor Analyst Jumps in SmarterAnalyst |
| 08:28AM | Novavax CEO: 'We have a vaccine we like' American City Business Journals |
| 08:00AM | Today's Research Reports on Stocks to Watch: Cytori Therapeutics and Novavax Accesswire |
| Jul-24-17 05:12PM | Why Novavax Stock Spiked Today Motley Fool |
| 04:41PM | Is There Life Left In The Novavax Clinical Program? Benzinga |
| 04:06PM | Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs GlobeNewswire |
| 07:00AM | Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes GlobeNewswire |
| Jul-23-17 08:40AM | 3 Stocks Under $5 That Could Make You Rich Motley Fool |
| Jul-22-17 02:03PM | Should Investors Brace for Bad News From Novavax's Looming Clinical Update? Motley Fool |
| Jul-21-17 09:30AM | Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM PR Newswire |
| Jul-18-17 04:34PM | Why Rite Aid, Novavax, and RH Jumped Today Motley Fool +27.19% |
| 12:17PM | Here's Why Novavax, Inc. Stock Popped Today Motley Fool |
| 08:00AM | Today's Research Reports on Trending Tickers: Puma Biotechnology Inc. and Novavax Inc. Accesswire |
| Jul-17-17 04:30PM | Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM PR Newswire |
| Jul-12-17 08:00AM | Why Novavax Stock Surged Higher in June Motley Fool |
| Jul-10-17 09:30AM | Zacks.com featured highlights: Ardelyx, Novavax, BioScrip, Layne Christensen and Resonant Zacks |
| Jul-07-17 09:40AM | Biotech Movers: Alexion, Arena, Novavax TheStreet.com |
| 08:41AM | 5 Breakout Stocks Offering Phenomenal Returns Zacks |
| Jun-08-17 08:00AM | Today's Research Reports on Stocks to Watch: Kite Pharma and Novavax Accesswire |
| Jun-07-17 11:12AM | These 2 Catalysts Are Behind Novavax, Inc.'s 12% Rise in May Motley Fool |
| 08:26AM | Novavax stock surges 6% after release of full mid-stage vaccine trial results MarketWatch |
| 08:05AM | Novavax RSV F Vaccine Phase 2 Clinical Trial Data in Women of Child Bearing Age Published in Vaccine PR Newswire |
| May-26-17 07:06AM | Can The Uptrend Continue for Novavax (NVAX)? Zacks |
| May-22-17 01:58PM | ETFs with exposure to Novavax, Inc. : May 22, 2017 Capital Cube |
| May-19-17 08:00AM | Today's Research Reports on Biotech Stocks to Watch: Novavax and Progenics Pharmaceuticals Accesswire |
| May-18-17 08:00AM | Novavax Financial Review, Analysts Target and Outlook Accesswire +5.83% |
| May-16-17 09:34AM | Biotech Movers: Akebia, Editas, Novavax TheStreet.com |
| 08:08AM | Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : May 16, 2017 Capital Cube |
| May-15-17 12:12PM | Here's What's Driving Up Novavax, Inc. Stock Again Today Motley Fool +9.00% |
| May-13-17 11:15PM | Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents |
| May-11-17 05:16PM | ETFs with exposure to Novavax, Inc. : May 11, 2017 Capital Cube +10.93% |
| 05:16PM | Here's What Is Pushing Up Novavax, Inc. Stock Today Motley Fool |
| 08:07AM | Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine GlobeNewswire |
| May-10-17 10:11AM | Novavax, Inc. :NVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube |
| May-09-17 03:17PM | Novavax shares jump on news of narrowed first-quarter losses American City Business Journals +15.68% |
| 11:40AM | Novavax, Inc Is Rising Today, but You Should Still Stay Far Away Motley Fool |
| 09:00AM | Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents |
| May-08-17 04:41PM | Novavax reports 1Q loss Associated Press |
| 04:13PM | Novavax Reports First Quarter 2017 Financial Results GlobeNewswire |
| 04:05PM | Novavax Reports First Quarter 2017 Financial Results GlobeNewswire |
| 11:00AM | Investor Network: Novavax, Inc. to Host Earnings Call Accesswire |
| May-01-17 04:55PM | No bonuses for Novavax following failed RSV vaccine trial American City Business Journals |
| 04:12PM | ETFs with exposure to Novavax, Inc. : May 1, 2017 Capital Cube |
| 11:13AM | Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire |
| 10:57AM | Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire |
| Apr-19-17 02:28PM | ETFs with exposure to Novavax, Inc. : April 19, 2017 Capital Cube |
| Apr-11-17 09:30AM | Biotech Movers Trading Positive Ahead of Market's Open TheStreet.com |
| Apr-07-17 05:11PM | ETFs with exposure to Novavax, Inc. : April 7, 2017 Capital Cube |
| 09:24AM | Down 12.5%: Is Novavax Stock Too Cheap To Ignore? Motley Fool |
| Apr-06-17 04:04PM | Valeant, DryShips Dont Escape Thursdays 52-Week Low Club 24/7 Wall St. -12.54% |
| 07:30AM | Today's Research Reports on Biotech Stocks to Watch: Sarepta Therapeutics and Novavax Accesswire |
| Apr-05-17 04:04PM | Valeant, DryShips Plunge into Wednesdays 52-Week Low Club 24/7 Wall St. -11.21% |
| 10:55AM | The Waiting Game Crushed Novavax, Inc. in March, Sending Shares Down 15% Motley Fool |
| 08:47AM | Implied Volatility Surging for Novavax (NVAX) Stock Options Zacks |
| Mar-31-17 08:05AM | 3 Companies That Might Not Live to See 2020 Motley Fool |
| Mar-27-17 04:02PM | ETFs with exposure to Novavax, Inc. : March 27, 2017 Capital Cube |
| 09:30AM | Biotech Industry Continues to Provide Investors with Gains in 2017: Today's Reports on Peregrine Pharmaceuticals and Novavax Accesswire |
| 06:55AM | The 6 Most Shorted Nasdaq Stocks 24/7 Wall St. |
| Mar-21-17 08:22AM | 3 Beaten-Up Biotech Stocks: Are They Bargains? Motley Fool -7.58% |
| Mar-20-17 08:59AM | Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube |
| Mar-16-17 09:30AM | Trade Volume Can Speak a Lot About Momentum of a Stock Accesswire |
| Mar-14-17 02:50PM | Novavax, Inc. :NVAX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 |
| Mar-09-17 12:40PM | These 5 Stocks Under $10 Could Ignite Soon |
| 07:47AM | These Popular Stocks Could Prove Toxic for Your Portfolio at Motley Fool |
| Mar-06-17 11:02AM | Why Novavax's Shares Marched Higher in February at Motley Fool |
| 09:30AM | Biotech's Rally in 2017 Gaining Steam After President Trump's Speech: Today's Reports on BioScrip and Novavax Accesswire |
| Mar-03-17 01:04PM | NOVAVAX INC Financials |
| Feb-28-17 07:02PM | NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -7.36% |
| 06:13PM | Here's Why Novavax, Inc.'s Share Price Went Down the Drain at Motley Fool |
| 11:03AM | 3 Stocks to Avoid in Biotech at Motley Fool |
| 10:10AM | Novavax: 'We still expect to enjoy the advantage of being the first RSV vaccine' at bizjournals.com |
| 09:45AM | Novavax Stock Spikes on Q4 Results at Investopedia |
| 09:22AM | Biotech Premarket Movers: Cempra, Novavax, Ionis |
|
|
|
|
| Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| YOUNG JAMES F | Director | Aug 31 | Sale | 1.06 | 175,000 | 184,870 | 0 | Sep 01 04:27 PM | | PHILLIPS BARCLAY A | SVP, Chief Financial Officer | Jul 31 | Buy | 0.89 | 2,057 | 1,831 | 38,669 | Aug 01 05:26 PM | | MCMANUS MICHAEL A JR | Director | May 12 | Buy | 0.97 | 20,000 | 19,396 | 277,590 | May 12 03:24 PM | | MCMANUS MICHAEL A JR | Director | May 11 | Buy | 0.84 | 10,000 | 8,400 | 257,590 | May 11 03:42 PM | | PHILLIPS BARCLAY A | SVP, Chief Financial Officer | May 11 | Buy | 0.84 | 25,000 | 20,950 | 36,612 | May 11 10:45 AM | | Erck Stanley C | President and CEO | May 11 | Buy | 0.84 | 50,000 | 41,980 | 128,279 | May 11 10:29 AM | | DOUGLAS RICHARD | Director | May 11 | Buy | 0.93 | 200,000 | 185,780 | 550,000 | May 12 09:59 AM | | YOUNG JAMES F | Director | Mar 14 | Sale | 1.39 | 100,000 | 138,980 | 175,000 | Mar 16 04:19 PM | | Trizzino John | SVP, Commercial Operations | Jan 31 | Buy | 1.12 | 3,401 | 3,809 | 88,965 | Feb 02 04:13 PM | | Herrmann John A III | SVP, General Counsel | Jan 31 | Buy | 1.12 | 4,960 | 5,555 | 7,072 | Feb 02 04:12 PM | | PHILLIPS BARCLAY A | SVP, Chief Financial Officer | Jan 31 | Buy | 1.12 | 1,633 | 1,829 | 11,612 | Feb 02 04:10 PM | | Glenn Gregory M | President, R&D | Dec 07 | Buy | 1.45 | 1,000 | 1,446 | 4,427 | Dec 07 04:29 PM | | Trizzino John | SVP, Commercial Operations | Sep 22 | Buy | 2.17 | 46,000 | 99,820 | 85,564 | Sep 23 05:21 PM | | DOUGLAS RICHARD | Director | Sep 21 | Buy | 1.72 | 100,000 | 172,010 | 350,000 | Sep 22 04:26 PM | | MCMANUS MICHAEL A JR | Director | Sep 21 | Buy | 1.61 | 30,000 | 48,297 | 247,590 | Sep 22 04:24 PM | | Glenn Gregory M | President, R&D | Sep 21 | Buy | 1.65 | 1,000 | 1,649 | 3,427 | Sep 22 04:20 PM |
|
|
|
|
|
|
